RIPE-KG · Version 1.1.0 · Resource

ripekg:work/10.1016%2Fs0140-6736%2808%2960203-2

https://w3id.org/ripe/ripe-kg/work/10.1016%2Fs0140-6736%2808%2960203-2
SubjectPredicateObject
ripekg:work/10.1016%2Fs0140-6736%2808%2960203-2Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a doubleblind randomised controlled trial prism:doi 10.1016/s0140-6736(08)60203-2
ripekg:work/10.1016%2Fs0140-6736%2808%2960203-2Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a doubleblind randomised controlled trial dcterms:title Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a doubleblind randomised controlled trial
ripekg:work/10.1016%2Fs0140-6736%2808%2960203-2Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a doubleblind randomised controlled trial rdf:type node1
ripekg:work/10.1016%2Fs0140-6736%2808%2960203-2Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a doubleblind randomised controlled trial rdf:type http://purl.org/spar/fabio/Work
ripekg:work/10.1016%2Fs0140-6736%2808%2960203-2Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a doubleblind randomised controlled trial rdf:type rdfs:Resource
ripekg:work/10.1016%2Fs0140-6736%2808%2960203-2Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a doubleblind randomised controlled trial rdf:type owl:Thing
ripekg:work/10.1016%2Fs0140-6736%2808%2960203-2Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a doubleblind randomised controlled trial rdf:type prov:Entity
ripekg:work/10.1016%2Fs0140-6736%2808%2960203-2Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a doubleblind randomised controlled trial rdf:type ripe:WorkWork
ripekg:work/10.1016%2Fs0140-6736%2808%2960203-2Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a doubleblind randomised controlled trial owl:sameAs https://semopenalex.org/work/W2119920607
ripekg:work/10.1136%2Fbmj-2025-084314Anti-CD38 monoclonal antibody CM313 for primary immune thrombocytopenia: multicentre, randomised, placebo controlled, phase 2 trial http://purl.org/spar/cito/cites ripekg:work/10.1016%2Fs0140-6736%2808%2960203-2Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a doubleblind randomised controlled trial